New Delhi, Feb. 25 -- The Indian Contract Research, Development, and Manufacturing Organization (CRDMO) sector is expected to touch USD 22 billion to USD 25 billion by 2035, according to a report by the Boston Consulting Group (BCG) and Innovative Pharmaceutical Services Organization (IPSO).

As per the report, India's CRDMO market is growing at a 15 per cent CAGR, outpacing global industry growth, fueled by its cost advantage over the West and 90 per cent faster project startup times.

The report also noted that Western pharmaceutical corporations are searching for alternate centres, while global supply chain realignments are opening up a USD 10 billion opportunity for Indian CRDMOs.

According to the report, new modalities like DNA and ...